Feed

Show only
24/11/2020
CMS ad­vises VR Equity­part­ner and MEH Beteili­gungs GmbH on sale of N3K Net­work...
Leipzig – VR Equity­part­ner and MEH Beteili­gungs GmbH have sold their shares in IT ser­vice pro­vider N3K Net­work Sys­tems to private equity firm In­vi­sion. Equity cap­it­al fin­an­ci­er VR Equity­part­ner and...
25 November 2020
CMS Ex­pert Guide to pop­u­lar in­vest­ment vehicles
This guide gives a quick re­view of some of the most pop­u­lar fund vehicles for in­sti­tu­tion­al in­vest­ment in real as­sets.The se­lec­tion of a vehicle has a num­ber of com­mon themes in­clud­ing the loc­a­tion of...
Comparable
01 December 2020
The Fu­ture is Now: The New World of Work
As coun­tries con­tin­ue to struggle with COV­ID-19 while also try­ing to re­tain at least a semb­lance of busi­ness as usu­al, the way we work has been changed ex­tens­ively, in some re­spects po­ten­tially forever.The...
24 November 2020
Single European Sky Per­form­ance Re­port 2019
On 29 Oc­to­ber 2020, the Single European Sky's per­form­ance re­view body pub­lished its re­port for 2019. This re­port also of­fers an in-depth over­view of the per­form­ance of air ser­vice pro­viders in the European...
19/11/2020
CMS ad­vises Kien­zle Auto­mot­ive on sale to Liberta Part­ners
Düs­sel­dorf – Liberta Part­ners, a multi-fam­ily hold­ing com­pany, has ac­quired Kien­zle Auto­mot­ive GmbH in the course of a suc­ces­sion part­ner­ship via Liberta Part­ners Fund II. Kien­zle Auto­mot­ive is a lead­ing...
09 November 2020
CMS Ex­pert Guide to mo­bile work­ing
Al­though chal­lenges brought on by the pan­dem­ic vary from coun­try to coun­try, COV­ID-19 has changed the way we work and do busi­ness. The situ­ation has also raised ques­tions: Will the pan­dem­ic's im­pact be...
Comparable
24 November 2020
Schrems II: Re­sponses to the su­per­vis­ory au­thor­it­ies' as­sess­ment and re­com­mend­a­tions...
"Schrems II": Opin­ions of the su­per­vis­ory au­thor­it­ies on Schrems II and re­com­mend­a­tions on the im­ple­ment­a­tion of the judge­ment in in­ter­na­tion­al data trans­fers On 16 Ju­ly 2020, the Court of Justice of...
17/11/2020
CMS ad­vises bi­otech com­pany Cherry Bio­labs on ex­clus­ive li­cence agree­ment...
Mu­nich – Bi­otech com­pany Cherry Bio­labs, a spin-off from Würzburg Uni­versity Hos­pit­al and an ex­clus­ive li­censee of Ju­li­us-Max­imili­ans-Uni­versity in Würzburg, has signed an ex­clus­ive sub-li­cence agree­ment...
27 October 2020
CMS Ex­pert Guide on sexu­al har­ass­ment in the work­place
Wel­come to our CMS Ex­pert Guide on sexu­al har­ass­ment in the work­place. How dif­fer­ent coun­tries re­spon­ded to the #MeT­oo move­ment and how the law reg­u­lates work­place har­ass­ment on a glob­al scale were key...
Comparable
23 November 2020
EU high court con­firms CBD is not a nar­cot­ic
In a long-awaited rul­ing, the European Court of Justice (ECJ) cla­ri­fied that the can­nabis act­ive in­gredi­ent Can­na­bi­d­i­ol (CBD) is not to be clas­si­fied as a nar­cot­ic. France sub­mits ques­tion on CBD in e-ci­gar­ettes...
17 November 2020
CMS Dis­putes Talk
In these un­cer­tain times, glob­al busi­nesses in al­most every sec­tor are fa­cing chal­lenges brought about by an un­pre­ced­en­ted op­er­a­tion­al cli­mate. Ac­tions and de­cisions taken dur­ing and im­me­di­ately after...
07 October 2020
CMS Ex­pert Guide to the private place­ment of equity se­cur­it­ies
One of the most com­mon ques­tions we are asked across CMS in our Equity Cap­it­al Mar­ket prac­tice is what are the rules about ap­proach­ing a lim­ited num­ber of in­vestors in dif­fer­ent jur­is­dic­tions, in re­la­tion...
Comparable